Laboratorios Ojer Pharma

Ojer Pharma is a pharmaceutical company, spin-off from the University of Navarra, founded under the auspices of the Center for Applied Pharmacobiology Research (CIFA), the Scientific and Technological Institute of Navarra (ICT), and the University Foundation of Navarra (FUNA). The company aims to develop innovative drugs and dermatological products to meet the needs of international patients. Ojer Pharma focuses on researching and developing products that address dermatological pathologies from a global perspective, targeting both the causes and symptoms. The ultimate goal is to become a hub for generating ideas, identifying gaps in the current dermatological market, and innovating the development of more effective and safer therapies. The company plans to commercialize these products through strong relationships with partners and collaborators. Founded in 2005, Ojer Pharma operates in the Pharmaceutical industry and is headquartered in Spain. The company recently received a €2.30M Private Equity Round investment on 24 March 2023 from investors including Inveready, Clave Mayor, EASO Ventures, and Dozen Investments.